ICU Medical profit growth


Intravenous products: The Wall Street Journal report “ICU Medical Inc.’s (ICUI) second-quarter profit grew by 20% as demand for the company’s disposable medical products was stable despite the economic downturn. The company also raised its full-year earnings, revenue and margins targets, due to improvements in its existing businesses as well as its acquisition of Hospira Inc.’s (HSP) critical-care product line, which is expected to close in the third quarter. The $35 million acquisition is expected to add 1 cent to 2 cents a share in the second half of the year”.

Click here for the full story.


Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.